Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
17
2024
December 2023 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Jan
17
2024
FDA Approves Florida Importing Drugs from Canada Greenberg Traurig, LLP
Jan
17
2024
FDA Recommends that the DEA Reschedule Marijuana Keller and Heckman LLP
Jan
16
2024
Law Library of Congress Publishes Report on Selected Issues in Biotechnology Regulation Bergeson & Campbell, P.C.
Jan
16
2024
CMS Proposes to Prohibit Overrides in Medicare Advantage McDermott Will & Emery
Jan
16
2024
Groundhog Day: Alabama Dispensary, Integrated Licenses Delayed (Again) Bradley Arant Boult Cummings LLP
Jan
16
2024
Arizona Moves to Ban Lab-Grown Meat Keller and Heckman LLP
Jan
16
2024
FDA Increasingly Active in ‘Off-Label’ Space Despite Patchwork Regulatory Scheme Greenberg Traurig, LLP
Jan
12
2024
China Continues to Revise the Food Labeling Standard Keller and Heckman LLP
Jan
12
2024
12 Days of Handbook Updates: Remote Workers Barnes & Thornburg LLP
Jan
11
2024
Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 Schwegman, Lundberg & Woessner, P.A.
Jan
11
2024
FDA says 87 Adverse Events Linked to Recalled Applesauce Keller and Heckman LLP
Jan
11
2024
Heads-Up: Oral Phenylephrine Products, Advisories and Lawsuits Womble Bond Dickinson (US) LLP
Jan
11
2024
City of Pittsburgh to Strictly Enforce Paid Sick Days Ordinance, Investigate Food Service Industry Jackson Lewis P.C.
Jan
11
2024
GRAS: Are Changes in Our Future? — A Conversation with Karin F. Baron [PODCAST] Bergeson & Campbell, P.C.
Jan
11
2024
FDA: Major Policy Shift Authorizes Florida’s Plan to Import Drugs from Canada Foley & Lardner LLP
Jan
11
2024
Don’t Assume Sweet Success: Forum Selection Clause Doesn’t Preclude IPR McDermott Will & Emery
Jan
11
2024
Hopping Towards Change: New Jersey Proposes A Crafty New Solution to the Special Ruling Norris McLaughlin P.A.
Jan
10
2024
Contracts Corner: Sponsorship Agreements McDermott Will & Emery
Jan
10
2024
EU Corporate Sustainability Due Diligence Directive Nearly Final Hunton Andrews Kurth
Jan
10
2024
California Court Applies Proposition 65 Safe Harbor in Dismissal Keller and Heckman LLP
Jan
9
2024
MoCRA Update for Starting the Year Off Right Beveridge & Diamond PC
Jan
9
2024
FDA’s Marketing Denial Order Issued to Bidi Vapor’s Non-Tobacco Flavored ENDS Products are Set Aside and Remanded by the 11th Circuit Court of Appeals for being Arbitrary and Capricious Keller and Heckman LLP
Jan
9
2024
5th Circuit Issues Blistering Critique of FDA’s Handling of PMTAs for E-Cigarettes Keller and Heckman LLP
Jan
9
2024
CORE Releases 2022 Annual Outbreak Report Keller and Heckman LLP
Jan
9
2024
Malta Initiative Survey on OECD Test Guidelines and Guidance Documents Will Close January 12 Bergeson & Campbell, P.C.
Jan
9
2024
Blazing Trails: Exploring ESOPs in the Cannabis Industry Bradley Arant Boult Cummings LLP
Jan
8
2024
Gold Dome Report – Legislative Day 1 (2024) Nelson Mullins
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins